A medicine can change hands many times before it reaches a patient. Manufacturers, contract manufacturers, logistics providers, wholesalers, hospitals and pharmacies may each maintain separate systems tracking the same package. That fragmentation creates opportunities for mistakes and counterfeit products, and the stakes are high: the World Health Organization has estimated that around one in ten medical products in low- and middle-income countries is substandard or falsified.

Blockchain offers a shared record in which supply-chain events can be timestamped and made difficult to alter after the fact. Part of the push is regulatory: the US Drug Supply Chain Security Act has been phasing in electronic, package-level traceability for prescription medicines, and comparable serialization rules apply in markets such as the European Union. That regulatory backdrop helps explain why most of the platforms below are built around GS1 and EPCIS standards rather than proprietary data formats. The market is less uniform than tokenized finance: some of the projects below run live pharmaceutical networks, while others are specialist deployments, pilots or underlying blockchain infrastructure. Their maturity varies considerably, and a proof of concept should not be confused with a nationwide production system.

Chronicled and MediLedger

Chronicled operates MediLedger, one of the strongest examples of blockchain becoming working infrastructure inside the pharmaceutical industry. The network connects manufacturers, wholesalers, group purchasing organizations and health systems around shared contract, customer and transaction information. MediLedger can distribute validated contract changes in real time and automate processes associated with pharmaceutical chargebacks — the rebates wholesalers deduct from manufacturers against negotiated prices, a long-running source of reconciliation work between trading partners. Chronicled currently cites users and participants including Johnson & Johnson, FFF Enterprises, Premier and Cardinal Health.

PharmaTrace

PharmaTrace is built specifically around pharmaceutical serialization and traceability. It ingests GS1 and EPCIS events from existing supply-chain systems and creates a tamper-evident product history through a blockchain verification layer. Sensitive commercial information remains access-controlled instead of being placed openly on a public ledger. The company says the platform is already used in production by pharmaceutical and specialty manufacturers and currently runs on Hyperledger Fabric and Hedera infrastructure.

Oracle Blockchain Platform

Oracle brings blockchain traceability into an enterprise technology stack that many pharmaceutical companies already understand. Its blockchain platform can combine distributed-ledger records with ERP, inventory, CRM, point-of-sale and IoT information. Oracle describes pharmaceutical use cases in which product movements and temperature excursions are recorded across the chain from manufacturer to point of sale. The technology can also track investigational medicines used in clinical studies and retain an audit trail for regulatory reporting.

StaTwig VaccineLedger

StaTwig built VaccineLedger around unit-level pharmaceutical tracking. Each product can receive a digital identity that follows it from supplier through distribution, while serialization and IoT information capture movements and storage conditions. The company has also deployed the technology in vaccine logistics: its GMR Hyderabad Air Cargo case study describes blockchain-based, real-time monitoring of vaccine shipments and handoffs between manufacturers, freight companies and logistics operators.

LedgerDomain BRUINchain

LedgerDomain tested blockchain at one of the most difficult points in the pharmaceutical chain: immediately before a medicine reaches a patient. Working with UCLA Health, it created BRUINchain to scan pharmaceutical barcodes, verify products and track physical custody inside a specialty pharmacy. The FDA-supported pilot used Hyperledger Fabric and demonstrated tracking down to individual refrigerator locations. The deployment was subsequently documented in peer-reviewed research.

VeChain

VeChain was one of the earliest public blockchain networks to build a dedicated drug and vaccine traceability model. Its system combined unique product identifiers with IoT devices capable of recording information such as transportation temperature and movement history onto VeChainThor. The pharmaceutical-specific work dates back several years, so it should be viewed as an early implementation rather than a new 2026 launch. VeChain nevertheless remains active as an enterprise-grade product-provenance network and reported more than 300,000 Digital Product Passport events through a separate industrial collaboration in early 2026.

TruTrace Technologies

TruTrace built blockchain software around product provenance and originally focused on highly regulated supply chains. Its technology subsequently expanded toward pharmaceuticals, food and other industries requiring traceability. In 2022, TruTrace announced an integration partnership with VeChain designed to combine its SaaS provenance system with VeChainThor. Although the collaboration is older than several projects on this list, it remains a useful example of specialist traceability software connecting regulated pharmaceutical supply chains with public blockchain infrastructure.

Wellgistics PharmacyChain

Wellgistics is developing PharmacyChain around smart contracts for pharmaceutical and healthcare transactions, integrating the platform with its EinsteinRx pharmacy technology and wider independent-pharmacy network. Its January 2026 outlook made clear that blockchain development was still being assessed and expanded rather than describing PharmacyChain as a fully mature national network. By May, Wellgistics said it was continuing to integrate PharmacyChain functionality with its pharmacy-dispensing infrastructure.

Alpha Technology Group

Alpha Technology Group provides one of the newest commercial examples, in the traditional-medicine segment. In June 2026, the Nasdaq-listed company announced a blockchain and AI traceability deployment with Hong Kong medicine company Wai Yuen Tong. The system is designed to record information covering medicinal-herb sourcing, processing, quality certification, GMP manufacturing and retail distribution. Unlike a conceptual white paper, Alpha described the partnership as the first commercial deployment of its proprietary traceability infrastructure in that market.

Hyperledger Fabric

Hyperledger Fabric is not a pharmaceutical company, but it is one of the most important underlying technologies in this sector. Permissioned networks built with Fabric can share selected information among approved trading partners while keeping commercially sensitive data private. BRUINchain used Fabric during its UCLA deployment, and PharmaTrace identifies Fabric as part of its production blockchain architecture. That makes Fabric less visible to pharmacists or patients but highly relevant as infrastructure beneath pharmaceutical traceability systems.

Blockchain will not solve every pharmaceutical supply-chain problem. A false temperature reading written permanently onto a ledger remains a false temperature reading, and reliable scanners, serialization standards and trusted trading partners still matter. Where blockchain can help is after reliable data has been created: it can make that information harder to alter, easier to reconcile across companies, and faster to retrieve when a regulator, wholesaler or pharmacist needs to know exactly where a medicine has been. For the sector, the near-term markers are concrete: whether early deployments such as Wellgistics' PharmacyChain and Alpha Technology Group's rollout with Wai Yuen Tong graduate into routine production use, and how the phased US unit-level traceability requirements continue to shape the systems being built.

This article first appeared on Metaverse Post.